Pharmion Vidaza Clears FDA With Full Approval For Bone Marrow Disorder
Pharmion plans to launch Vidaza for the treatment of myelodysplastic syndromes in July, following FDA approval May 19
Pharmion plans to launch Vidaza for the treatment of myelodysplastic syndromes in July, following FDA approval May 19